Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review)

Standard

Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). / Müller, I; Niethammer, D; Bruchelt, G.

In: INT J MOL MED, Vol. 1, No. 2, 02.1998, p. 491-4.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{75cfa316c7424d7d8889b86841f083ee,
title = "Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review)",
abstract = "Anthracycline-derivatives are frequently used chemotherapeutics in treatment of numerous human malignancies. Anthracyclines are known for their complex cytotoxic mechanism involving i) inhibition of enzymes such as topoisomerase II, RNA polymerase, cytochrome c oxidase and others; ii) intercalation into DNA; iii) chelation of iron and generation of reactive oxygen species (ROS); iv) induction of apoptosis. Here, mechanistic aspects for successful cytostasis and for side effects, e.g. cardiomyopathy, are discussed. We emphasize recent developments in anthracycline-mediated apoptosis and focus on a well known representative, doxorubicin (adriamycin, adriblastin). We reflect on the role of oxidative stress and interactions with intracellular signaling pathways.",
keywords = "Animals, Anthracyclines, Apoptosis, Calcium-Calmodulin-Dependent Protein Kinases, Doxorubicin, Drug Resistance, Free Radicals, Humans, JNK Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinases",
author = "I M{\"u}ller and D Niethammer and G Bruchelt",
year = "1998",
month = feb,
language = "English",
volume = "1",
pages = "491--4",
journal = "INT J MOL MED",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "2",

}

RIS

TY - JOUR

T1 - Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review)

AU - Müller, I

AU - Niethammer, D

AU - Bruchelt, G

PY - 1998/2

Y1 - 1998/2

N2 - Anthracycline-derivatives are frequently used chemotherapeutics in treatment of numerous human malignancies. Anthracyclines are known for their complex cytotoxic mechanism involving i) inhibition of enzymes such as topoisomerase II, RNA polymerase, cytochrome c oxidase and others; ii) intercalation into DNA; iii) chelation of iron and generation of reactive oxygen species (ROS); iv) induction of apoptosis. Here, mechanistic aspects for successful cytostasis and for side effects, e.g. cardiomyopathy, are discussed. We emphasize recent developments in anthracycline-mediated apoptosis and focus on a well known representative, doxorubicin (adriamycin, adriblastin). We reflect on the role of oxidative stress and interactions with intracellular signaling pathways.

AB - Anthracycline-derivatives are frequently used chemotherapeutics in treatment of numerous human malignancies. Anthracyclines are known for their complex cytotoxic mechanism involving i) inhibition of enzymes such as topoisomerase II, RNA polymerase, cytochrome c oxidase and others; ii) intercalation into DNA; iii) chelation of iron and generation of reactive oxygen species (ROS); iv) induction of apoptosis. Here, mechanistic aspects for successful cytostasis and for side effects, e.g. cardiomyopathy, are discussed. We emphasize recent developments in anthracycline-mediated apoptosis and focus on a well known representative, doxorubicin (adriamycin, adriblastin). We reflect on the role of oxidative stress and interactions with intracellular signaling pathways.

KW - Animals

KW - Anthracyclines

KW - Apoptosis

KW - Calcium-Calmodulin-Dependent Protein Kinases

KW - Doxorubicin

KW - Drug Resistance

KW - Free Radicals

KW - Humans

KW - JNK Mitogen-Activated Protein Kinases

KW - Mitogen-Activated Protein Kinases

M3 - SCORING: Journal article

C2 - 9852255

VL - 1

SP - 491

EP - 494

JO - INT J MOL MED

JF - INT J MOL MED

SN - 1107-3756

IS - 2

ER -